Real-time enrollment status for this primary membranous nephropathy clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:52 AM UTC
| NCT Number | NCT07157787 |
| Recruiting Status | Recruiting |
| Condition | Primary Membranous Nephropathy |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Alexion Pharmaceuticals, Inc. |
| Last Updated on CT.gov | February 12, 2026 (2 weeks ago) |
As of March 2, 2026: Clinical trial NCT07157787 is currently recruiting participants. This clinical trial study for primary membranous nephropathy is actively seeking new participants at 5 locations across the United States. The study is sponsored by Alexion Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07157787 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07157787 was last updated 2 weeks ago (February 12, 2026). HelloStudys verifies this status automatically.